Concepedia
Statistics
Publications
20
Citations
2.1K
H-Index
17
Active since
1989
Affiliations
Pfizer (United States)(Current)
Newcastle University
University of California, Irvine
University of Minnesota
Donald J. Skalitzky is an author at Pfizer (United States) specializing in organic chemistry, pharmacology, and chemistry.
Top concepts
PharmacologyOrganic ChemistryChemistryMedicineEngineeringBiochemistryBiomolecular EngineeringDrug DiscoveryPharmacotherapyDrug Development
Publications per year
1989–2021
Anticancer Chemosensitization and Radiosensitization by the Novel Poly(ADP-ribose) Polymerase-1 Inhibitor AG14361
Christopher Calabrese, Robert J. Almassy, Stephen Barton et al. · JNCI Journal of the National Cancer Institute · 2004 · 482 citations · Full text
Stereochemistry of alternating polyol chains: 13C NMR analysis of 1,3-diol acetonides
Scott D. Rychnovsky, Donald J. Skalitzky · Tetrahedron Letters · 1990 · 477 citations
Engineering, Organic Chemistry, 1,3-Diol Acetonides +8
Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial
Huw D. Thomas, Christopher Calabrese, Michael A. Batey et al. · Molecular Cancer Therapeutics · 2007 · 297 citations
Tricyclic Benzimidazoles as Potent Poly(ADP-ribose) Polymerase-1 Inhibitors
Donald J. Skalitzky, Joseph Marakovits, Karen A. Maegley et al. · Journal of Medicinal Chemistry · 2002 · 152 citations · Full text
Medicinal Chemistry, Tricyclic Benzimidazoles, Bioorganic Chemistry +13
Optically pure 1,3-diols from (2R,4R)- and (2S,4S)-1,2:4,5-diepoxypentane
Scott D. Rychnovsky, George Griesgraber, Sam Zeller et al. · The Journal of Organic Chemistry · 1991 · 107 citations
Altmetrics, Derivative (Chemistry), Engineering +12
1–5 of 20